null

Abituzumab Biosimilar (Anti-ITGAV) Antibody (HDBS0141)

(No reviews yet) Write a Review
SKU:
HDBS0141
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Protein:
ITGAV
Reactivity:
Human
Host Species:
Human
Isotype:
IgG2
€399

Description

system_update_altDatasheet

Abituzumab (Anti-ITGAV) Biosimilar Antibody (HDBS0141)

The Abituzumab Biosimilar Anti-ITGAV Antibody is a cutting-edge tool for researchers studying integrin alpha V (ITGAV), a cell surface receptor involved in numerous physiological processes, including cell adhesion, migration, and signaling. This biosimilar antibody, developed as an alternative to the original Abituzumab antibody, offers high specificity and sensitivity for detecting ITGAV in human samples.Raised in a specialized production process, this antibody is rigorously tested for its ability to bind specifically to the ITGAV protein in Western blot and immunohistochemistry applications.

Its versatility allows for thorough analysis of ITGAV expression in different cell types and tissues, making it an invaluable asset for investigations in oncology, inflammation, and tissue remodeling.The role of ITGAV in cancer progression, angiogenesis, and metastasis has sparked significant interest in targeting this protein for therapeutic interventions. By utilizing the Abituzumab Biosimilar Anti-ITGAV Antibody, researchers can gain deeper insights into the molecular mechanisms involving ITGAV and potentially identify new opportunities for developing novel anti-cancer therapies.

0 Reviews

View AllClose